Journal of Affective Disorders
Volume 75, Issue 1 , Pages 77-82 , June 2003

Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls

  • Eva Albertsen Malt

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Psychosomatic Medicine, Rikshospitalet, 0027 Oslo, Norway. Tel.: +47-2307-4920; fax: +47-2307-4930
    • Research Fellow, Department of Psychiatry, University of Bergen, Norway.
  • ,
  • Snorri Olafsson

      Affiliations

    • Research Fellow, Department of Internal Medicine, University of Bergen, Norway.
  • ,
  • Asbjoern Aakvaag

      Affiliations

    • Professor, Institute of Clinical Biochemistry, University of Bergen, Norway.
  • ,
  • Anders Lund

      Affiliations

    • Assisant Professor, Department of Psychiatry, University of Bergen, Norway.
  • ,
  • Holger Ursin

      Affiliations

    • Professor, Department of Biological and Medical Psychology, Division of Physiological Psychology University of Bergen, Norway.

Received 6 March 2001 ,Revised 10 January 2002 ,Accepted 15 January 2002.

References 

  1. Alfici S, Sigal M, Landau M. Primary fibromyalgia syndrome—a variant of depressive disorder?. Psychother. Psychosom. 1989;51:156–161
  2. Bakheit AM, Behan PO, Dinan TG, Gray CE, O’Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br. Med. J. 1992;304:1010–1012
  3. Chua A, Keating J, Hamilton D, Keeling PW, Dinan TG. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. Br. Med. J. 1992;305:280–282
  4. Cleare AJ, Forsling M, Bond AJ. Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study. Int. Clin. Psychopharmacol. 1998;13:23–32
  5. Cowen PJ, Anderson IM, Grahame Smith DG. Neuroendocrine effects of azapirones. J. Clin. Psychopharmacol. 1990;10:21S–25S
  6. Cowen PJ, Power AC, Ware CJ, Anderson IM. 5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br. J. Psychiatry. 1994;164:372–379
  7. Dinan TG, Barry S, Yatham LN, Mobayed M, O’Hanlon M. The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle. Int. Clin. Psychopharmacol. 1990;5:119–123
  8. Dinan TG, Yatham LN, Barry S, Chua A, Keeling PW. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia? A preliminary report of buspirone/prolactin responses. Scand. J. Gastroenterol. 1990;25:541–544
  9. Hudson JI, Pope HG. Fibromyalgia and psychopathology: is fibromyalgia a form of ‘affective spectrum disorder’?. J. Rheumatol. Suppl. 1989;19:15–22
  10. Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Bailliere’s Clin. Rheumatol. 1994;8:839–856
  11. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am. J. Med. 1992;92:363–367
  12. Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G, Schulte HM. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 1990;46:1271–1277
  13. MacLennan AJ, Pelleymounter MA, Atmadja S, Jakubovic A, Maier SF, Fibiger HC. D2 dopamine receptors in the rat prefrontal cortex: characterization and alteration by stress. Brain Res. 1989;477:300–307
  14. Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol. 2001;23:117–122
  15. Malt EA, Berle J, Olafsson S, Lund A, Ursin H. Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls. J. Psychosom. Res. 2000;49:285–289
  16. Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ. Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol. Psychiatry. 1995;38:235–239
  17. Mc Ivor RJ, Davies RA, Wieck A, Marks MN, Brown N, Campbell IC, et al. The growth hormone response to apomorphine at 4 days postpartum in women with a history of major depression. J. Affect. Disord. 1996;40:131–136
  18. Meltzer HY, Fleming R. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man. J. Clin. Psychiatry. 1982;43:76–79
  19. Meltzer HY, Lee HS, Nash JF. Effect of buspirone on prolactin secretion is not mediated by 5-HT-1a receptor stimulation. Arch. Gen. Psychiatry. 1992;49:163–164
  20. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand. J. Rheumatol. Suppl. 2000;113:8–12
  21. Noble EP. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics. 2000;1:309–333
  22. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 1999;42:2482–2488
  23. Peroutka S-J. Dopamine and migraine. Neurology. 1997;49(3):650–656
  24. Rasmussen Dennis DA. Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology. 1998;23:259
  25. Sharpe M, Clements A, Hawton K, Young AH, Sargent P, Cowen PJ. Increased prolactin response to buspirone in chronic fatigue syndrome. J. Affect. Disord. 1996;41:71–76
  26. SPSS Inc.. SPSS For Windows (version 9). Chicago: SPSS Inc; 1999;
  27. Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, et al. Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis. Med. Klin. 1993;88:458–462
  28. Tanum L, Malt UF. Sodium lactate infusion in fibromyalgia patients. Biol. Psychiatry. 1995;38:559–561
  29. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172

PII: S0165-0327(02)00025-3

doi: 10.1016/S0165-0327(02)00025-3

Journal of Affective Disorders
Volume 75, Issue 1 , Pages 77-82 , June 2003